APO Research
Talk to an analyst

APO RESEARCH · REPORT

Varicella Vaccine

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin

Selected research

Industry Growth & Trends

Global Varicella Vaccine Industry Growth and Trends Forecast to 2032

23 December 202599 pages

Choose your research edition.

Industry ResearchVaricella Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Varicella Vaccine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Varicella Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Varicella Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Varicella Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin

Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.

Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.

Read the full market overview

In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.

Report Scope

This report provides a structured, data-driven view of the global Varicella Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Varicella Vaccine market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Varicella Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Varicella Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Varicella Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Varicella Vaccine Market by Company

Merck

GSK

Shanghai Institute

BCHT

Changsheng

Keygen

Green Cross

Biken

Varicella Vaccine Segment by Type

Injection

Freeze-Dried Powder

Varicella Vaccine Segment by Application

Kids Injection

Adults Injection

Varicella Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Varicella Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Varicella Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Varicella Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Varicella Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Varicella Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Freeze-Dried Powder Table 3. Global Varicella Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Varicella Vaccine Sales by Type (2021-2026) & (M Doses) Table 5. Global Varicella Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Varicella Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Varicella Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Varicella Vaccine Price by Type (2021-2026) & (USD/Dose) Table 9. Global Varicella Vaccine Sales by Type (2027-2032) & (M Doses) Table 10. Global Varicella Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Varicella Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Varicella Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Varicella Vaccine Price by Type (2027-2032) & (USD/Dose) Table 14. North America Varicella Vaccine Sales by Type (2021-2026) & (M Doses) Table 15. North America Varicella Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Varicella Vaccine Sales by Type (2021-2026) & (M Doses) Table 17. Europe Varicella Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Varicella Vaccine Sales by Type (2021-2026) & (M Doses) Table 19. Asia-Pacific Varicella Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Varicella Vaccine Sales by Type (2021-2026) & (M Doses) Table 21. Latin America Varicella Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Varicella Vaccine Sales by Type (2021-2026) & (M Doses) Table 23. Middle East and Africa Varicella Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Varicella Vaccine Industry Trends Table 25. Varicella Vaccine Industry Drivers Table 26. Varicella Vaccine Industry Opportunities and Challenges Table 27. Varicella Vaccine Industry Restraints Table 28. Global Varicella Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Varicella Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Varicella Vaccine Sales by Company (2021-2026) & (M Doses) Table 31. Global Varicella Vaccine Sales Share by Company (2021-2026) Table 32. Global Varicella Vaccine Market Price by Company (2021-2026) & (USD/Dose) Table 33. Global Varicella Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Varicella Vaccine Major Company Production Sites and Headquarters Table 35. Global Varicella Vaccine Company, Product Type & Application Table 36. Global Varicella Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Varicella Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Varicella Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Varicella Vaccine Sales by Region (2021-2026) & (M Doses) Table 41. Global Varicella Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Varicella Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Varicella Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Varicella Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 45. Global Varicella Vaccine Sales by Region (2027-2032) & (M Doses) Table 46. Global Varicella Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Varicella Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Varicella Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Varicella Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2027-2032) Table 50. Global Varicella Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Varicella Vaccine Sales by Application (2021-2026) & (M Doses) Table 52. Global Varicella Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Varicella Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Varicella Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Varicella Vaccine Price by Application (2021-2026) & (USD/Dose) Table 56. Global Varicella Vaccine Sales by Application (2027-2032) & (M Doses) Table 57. Global Varicella Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Varicella Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Varicella Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Varicella Vaccine Price by Application (2027-2032) & (USD/Dose) Table 61. North America Varicella Vaccine Sales by Application (2021-2026) & (M Doses) Table 62. North America Varicella Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Varicella Vaccine Sales by Application (2021-2026) & (M Doses) Table 64. Europe Varicella Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Varicella Vaccine Sales by Application (2021-2026) & (M Doses) Table 66. Asia-Pacific Varicella Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Varicella Vaccine Sales by Application (2021-2026) & (M Doses) Table 68. Latin America Varicella Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Varicella Vaccine Sales by Application (2021-2026) & (M Doses) Table 70. Middle East and Africa Varicella Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 74. Merck Varicella Vaccine Product Portfolio Table 75. Merck Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 79. GSK Varicella Vaccine Product Portfolio Table 80. GSK Recent Development Table 81. Shanghai Institute Company Information Table 82. Shanghai Institute Business Overview Table 83. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 84. Shanghai Institute Varicella Vaccine Product Portfolio Table 85. Shanghai Institute Recent Development Table 86. BCHT Company Information Table 87. BCHT Business Overview Table 88. BCHT Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 89. BCHT Varicella Vaccine Product Portfolio Table 90. BCHT Recent Development Table 91. Changsheng Company Information Table 92. Changsheng Business Overview Table 93. Changsheng Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 94. Changsheng Varicella Vaccine Product Portfolio Table 95. Changsheng Recent Development Table 96. Keygen Company Information Table 97. Keygen Business Overview Table 98. Keygen Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 99. Keygen Varicella Vaccine Product Portfolio Table 100. Keygen Recent Development Table 101. Green Cross Company Information Table 102. Green Cross Business Overview Table 103. Green Cross Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 104. Green Cross Varicella Vaccine Product Portfolio Table 105. Green Cross Recent Development Table 106. Biken Company Information Table 107. Biken Business Overview Table 108. Biken Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 109. Biken Varicella Vaccine Product Portfolio Table 110. Biken Recent Development Table 111. North America Varicella Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 112. North America Varicella Vaccine Sales by Country (2021-2026) & (M Doses) Table 113. North America Varicella Vaccine Sales Market Share by Country (2021-2026) Table 114. North America Varicella Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 115. North America Varicella Vaccine Sales Market Share Forecast by Country (2027-2032) Table 116. North America Varicella Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Varicella Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Varicella Vaccine Market Share by Country (2021-2026) Table 119. North America Varicella Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Varicella Vaccine Market Share Forecast by Country (2027-2032) Table 121. Europe Varicella Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 122. Europe Varicella Vaccine Sales by Country (2021-2026) & (M Doses) Table 123. Europe Varicella Vaccine Sales Market Share by Country (2021-2026) Table 124. Europe Varicella Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 125. Europe Varicella Vaccine Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Varicella Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Varicella Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Varicella Vaccine Market Share by Country (2021-2026) Table 129. Europe Varicella Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Varicella Vaccine Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Varicella Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Varicella Vaccine Sales by Country (2021-2026) & (M Doses) Table 133. Asia-Pacific Varicella Vaccine Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Varicella Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 135. Asia-Pacific Varicella Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Varicella Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Varicella Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Varicella Vaccine Market Share by Country (2021-2026) Table 139. Asia-Pacific Varicella Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Varicella Vaccine Market Share Forecast by Country (2027-2032) Table 141. Latin America Varicella Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 142. Latin America Varicella Vaccine Sales by Country (2021-2026) & (M Doses) Table 143. Latin America Varicella Vaccine Sales Market Share by Country (2021-2026) Table 144. Latin America Varicella Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 145. Latin America Varicella Vaccine Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Varicella Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Varicella Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Varicella Vaccine Market Share by Country (2021-2026) Table 149. Latin America Varicella Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Varicella Vaccine Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Varicella Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Varicella Vaccine Sales by Country (2021-2026) & (M Doses) Table 153. Middle East and Africa Varicella Vaccine Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Varicella Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 155. Middle East and Africa Varicella Vaccine Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Varicella Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Varicella Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Varicella Vaccine Market Share by Country (2021-2026) Table 159. Middle East and Africa Varicella Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Varicella Vaccine Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Varicella Vaccine Distributors List Table 164. Varicella Vaccine Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Varicella Vaccine Image Figure 2. Global Varicella Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Varicella Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Varicella Vaccine Sales (2021-2032) & (M Doses) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (M Doses) Figure 7. Freeze-Dried Powder Image Figure 8. Global Freeze-Dried Powder Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Global Varicella Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Varicella Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Varicella Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Varicella Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Varicella Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Varicella Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Varicella Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Varicella Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Varicella Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Varicella Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Varicella Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Varicella Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Varicella Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Kids Injection Image Figure 24. Global Kids Injection Sales YoY Growth (2021-2032) & (M Doses) Figure 25. Adults Injection Image Figure 26. Global Adults Injection Sales YoY Growth (2021-2032) & (M Doses) Figure 27. Global Varicella Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Varicella Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Varicella Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Varicella Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Varicella Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Varicella Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Varicella Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Varicella Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Varicella Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Varicella Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Varicella Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Varicella Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Varicella Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 40. North America Varicella Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Varicella Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Varicella Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Varicella Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 44. Europe Varicella Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Varicella Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Varicella Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Varicella Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 48. Asia-Pacific Varicella Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Varicella Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Varicella Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Varicella Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 52. Latin America Varicella Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Varicella Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Varicella Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Varicella Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 56. Middle East and Africa Varicella Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Varicella Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Varicella Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Varicella Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Varicella Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Freeze-Dried Powder
Applications
  • Kids Injection
  • Adults Injection
Companies covered
  • Merck
  • GSK
  • Shanghai Institute
  • BCHT
  • Changsheng
  • Keygen
  • Green Cross
  • Biken

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Varicella Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Varicella Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Varicella Vaccine Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Freeze-Dried Powder
  8. 1.4 Global Varicella Vaccine Market Size by Type
  9. 1.4.1 Global Varicella Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Varicella Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Varicella Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Varicella Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Varicella Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Varicella Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Varicella Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Varicella Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Varicella Vaccine Industry Trends
  2. 2.2 Varicella Vaccine Industry Drivers
  3. 2.3 Varicella Vaccine Industry Opportunities and Challenges
  4. 2.4 Varicella Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Varicella Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Varicella Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Varicella Vaccine Price (2021-2026)
  4. 3.4 Global Varicella Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Varicella Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Varicella Vaccine Company, Product Type & Application
  7. 3.7 Global Varicella Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Varicella Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Varicella Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Varicella Vaccine Tier 1, Tier 2, and Tier 3
4 Varicella Vaccine Regional Status and Outlook
  1. 4.1 Global Varicella Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Varicella Vaccine Historic Market Size by Region
  3. 4.2.1 Global Varicella Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Varicella Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Varicella Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Varicella Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Varicella Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Varicella Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Varicella Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Varicella Vaccine by Application
  1. 5.1 Varicella Vaccine Market by Application
  2. 5.1.1 Kids Injection
  3. 5.1.2 Adults Injection
  4. 5.2 Global Varicella Vaccine Market Size by Application
  5. 5.2.1 Global Varicella Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Varicella Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Varicella Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Varicella Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Varicella Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Varicella Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Varicella Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Varicella Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Varicella Vaccine Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Varicella Vaccine Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Shanghai Institute
  14. 6.3.1 Shanghai Institute Company Information
  15. 6.3.2 Shanghai Institute Business Overview
  16. 6.3.3 Shanghai Institute Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Institute Varicella Vaccine Product Portfolio
  18. 6.3.5 Shanghai Institute Recent Developments
  19. 6.4 BCHT
  20. 6.4.1 BCHT Company Information
  21. 6.4.2 BCHT Business Overview
  22. 6.4.3 BCHT Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BCHT Varicella Vaccine Product Portfolio
  24. 6.4.5 BCHT Recent Developments
  25. 6.5 Changsheng
  26. 6.5.1 Changsheng Company Information
  27. 6.5.2 Changsheng Business Overview
  28. 6.5.3 Changsheng Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Changsheng Varicella Vaccine Product Portfolio
  30. 6.5.5 Changsheng Recent Developments
  31. 6.6 Keygen
  32. 6.6.1 Keygen Company Information
  33. 6.6.2 Keygen Business Overview
  34. 6.6.3 Keygen Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Keygen Varicella Vaccine Product Portfolio
  36. 6.6.5 Keygen Recent Developments
  37. 6.7 Green Cross
  38. 6.7.1 Green Cross Company Information
  39. 6.7.2 Green Cross Business Overview
  40. 6.7.3 Green Cross Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Green Cross Varicella Vaccine Product Portfolio
  42. 6.7.5 Green Cross Recent Developments
  43. 6.8 Biken
  44. 6.8.1 Biken Company Information
  45. 6.8.2 Biken Business Overview
  46. 6.8.3 Biken Varicella Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biken Varicella Vaccine Product Portfolio
  48. 6.8.5 Biken Recent Developments
7 North America by Country
  1. 7.1 North America Varicella Vaccine Sales by Country
  2. 7.1.1 North America Varicella Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Varicella Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Varicella Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Varicella Vaccine Market Size by Country
  6. 7.2.1 North America Varicella Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Varicella Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Varicella Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Varicella Vaccine Sales by Country
  2. 8.1.1 Europe Varicella Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Varicella Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Varicella Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Varicella Vaccine Market Size by Country
  6. 8.2.1 Europe Varicella Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Varicella Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Varicella Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Varicella Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Varicella Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Varicella Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Varicella Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Varicella Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Varicella Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Varicella Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Varicella Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Varicella Vaccine Sales by Country
  2. 10.1.1 South America Varicella Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Varicella Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Varicella Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Varicella Vaccine Market Size by Country
  6. 10.2.1 South America Varicella Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Varicella Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Varicella Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Varicella Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Varicella Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Varicella Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Varicella Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Varicella Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Varicella Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Varicella Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Varicella Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Varicella Vaccine Value Chain Analysis
  2. 12.1.1 Varicella Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Varicella Vaccine Production Mode & Process
  7. 12.2 Varicella Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Varicella Vaccine Distributors
  10. 12.2.3 Varicella Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst